AMN Healthcare forecasts Q3 2026 adjusted EBITDA margin 6.5%-7%

• AMN Healthcare issued Q3 2026 guidance for adjusted EBITDA margin of about 6.5% to 7%.
• Guidance implies operating margin of about 0.2% to 0.8%, depreciation and amortization of about 4.9% to 5%.
• Bridge to adjusted EBITDA margin includes share-based compensation of about 1.1%, integration and other costs of about 0.2%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AMN Healthcare Services Inc. published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.